Invivyd Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
IVVD Nasdaq 8731 https://adagiotx.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Invivyd Inc

Invivyd Receives Healthcare Common Procedure Coding System (HCPCS) Reimbursement Codes from the U.S. Centers for Medicare & Medicaid Services (CMS) Covering PEMGARDA™ - Apr 15th, 2024 11:30 am
Invivyd Announces CEO Transition - Apr 12th, 2024 11:30 am
We're Keeping An Eye On Invivyd's (NASDAQ:IVVD) Cash Burn Rate - Apr 7th, 2024 1:47 pm
Invivyd Provides PEMGARDA™ Launch Update and Announces 2024 Net Product Revenue Guidance in the Range of $150 Million to $200 Million - Apr 4th, 2024 8:01 pm
Invivyd Reports Full Year 2023 Financial Results and Recent Business Highlights - Mar 28th, 2024 11:00 am
Invivyd Announces Interim Exploratory Data on VYD222 from Ongoing CANOPY Clinical Trial - Mar 22nd, 2024 7:28 pm
Invivyd Announces FDA Authorization for Emergency Use of PEMGARDA™ (Formerly VYD222) for Pre-exposure Prophylaxis (PrEP) of COVID-19 - Mar 22nd, 2024 7:04 pm
Invivyd to Participate at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference - Feb 5th, 2024 9:02 pm
3 Groundbreaking Biotech Stocks to Invest in Now - Jan 29th, 2024 5:35 pm
When Will Invivyd, Inc. (NASDAQ:IVVD) Become Profitable? - Jan 19th, 2024 12:33 pm
All You Need to Know About Invivyd, Inc. (IVVD) Rating Upgrade to Strong Buy - Jan 12th, 2024 5:00 pm
Invivyd Submits Request for Emergency Use Authorization (EUA) to U.S. FDA for VYD222 for the Pre-exposure Prevention of COVID-19 in Immunocompromised Adults and Adolescents - Jan 3rd, 2024 12:00 pm
Invivyd Stock More Than Doubled Last Week. Is It Too Late to Buy? - Dec 23rd, 2023 10:29 am
Invivyd (IVVD) Surges on Positive Data From COVID-19 Study - Dec 19th, 2023 4:52 pm
Invivyd Announces Positive Initial Results from Ongoing CANOPY Phase 3 Pivotal Clinical Trial Investigating VYD222 for the Prevention of COVID-19 - Dec 18th, 2023 12:00 pm
Invivyd, Inc. (NASDAQ:IVVD) Q3 2023 Earnings Call Transcript - Nov 13th, 2023 3:21 pm
Q3 2023 Invivyd Inc Earnings Call - Nov 10th, 2023 1:35 pm
Invivyd Reports Third Quarter 2023 Financial Results and Recent Business Highlights - Nov 9th, 2023 9:01 pm
Invivyd to Host Conference Call Discussing Third Quarter 2023 Financial Results and Business Highlights - Nov 2nd, 2023 8:01 pm
Invivyd to Participate in Upcoming Investor Conferences - Oct 31st, 2023 8:01 pm